RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bavarian Nordic A/S Stock

Bavarian Nordic A/S Net Income 2024

Bavarian Nordic A/S Net Income

814.8 M DKK

Ticker

BAVA.CO

ISIN

DK0015998017

WKN

917165

In 2024, Bavarian Nordic A/S's profit amounted to 814.8 M DKK, a -44.77% increase from the 1.48 B DKK profit recorded in the previous year.

The Bavarian Nordic A/S Net Income history

YEARNET INCOME (undefined DKK)
2029e-
2028e0.94
2027e0.72
2026e0.78
2025e0.67
2024e0.81
20231.48
2022-0.35
2021-0.46
20200.28
2019-0.35
2018-0.36
20170.18
20160.03
20150.06
20140.03
2013-0.05
2012-0.24
2011-0.27
2010-0.39
2009-0.27
2008-0.15
2007-0.06
2006-0.16
2005-0.09
2004-0.05

Bavarian Nordic A/S Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Bavarian Nordic A/S, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bavarian Nordic A/S from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bavarian Nordic A/S’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bavarian Nordic A/S. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bavarian Nordic A/S’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bavarian Nordic A/S’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bavarian Nordic A/S’s growth potential.

Bavarian Nordic A/S Revenue, EBIT and net profit per share

DateBavarian Nordic A/S RevenueBavarian Nordic A/S EBITBavarian Nordic A/S Net Income
2029e6.76 B DKK0 DKK0 DKK
2028e6.04 B DKK1.81 B DKK935.22 M DKK
2027e5.68 B DKK1.55 B DKK723.03 M DKK
2026e4.93 B DKK987.87 M DKK784.59 M DKK
2025e4.77 B DKK867.51 M DKK672.51 M DKK
2024e5.43 B DKK911.37 M DKK814.8 M DKK
20237.06 B DKK2.12 B DKK1.48 B DKK
20223.15 B DKK-70.79 M DKK-347.38 M DKK
20211.9 B DKK-312.93 M DKK-464.78 M DKK
20201.85 B DKK395.65 M DKK277.52 M DKK
2019662.49 M DKK-328.45 M DKK-346.78 M DKK
2018500.62 M DKK-354.48 M DKK-361.93 M DKK
20171.37 B DKK353.19 M DKK181.34 M DKK
20161.01 B DKK35.41 M DKK30.6 M DKK
20151.02 B DKK13.55 M DKK59.43 M DKK
20141.22 B DKK16.68 M DKK25.94 M DKK
20131.21 B DKK33.4 M DKK-46.7 M DKK
20121.02 B DKK-31.7 M DKK-240 M DKK
2011523.6 M DKK-308.3 M DKK-268.4 M DKK
2010314.1 M DKK-474.1 M DKK-389.9 M DKK
200974.8 M DKK-341.2 M DKK-266.3 M DKK
2008208.8 M DKK-209.5 M DKK-146.1 M DKK
2007332.1 M DKK-65 M DKK-60 M DKK
2006175.3 M DKK-203.8 M DKK-158 M DKK
2005247.6 M DKK-119.8 M DKK-94.1 M DKK
2004164.8 M DKK-82.3 M DKK-53 M DKK

Bavarian Nordic A/S stock margins

The Bavarian Nordic A/S margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bavarian Nordic A/S. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bavarian Nordic A/S.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bavarian Nordic A/S's sales revenue. A higher gross margin percentage indicates that the Bavarian Nordic A/S retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bavarian Nordic A/S's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bavarian Nordic A/S's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bavarian Nordic A/S's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bavarian Nordic A/S. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bavarian Nordic A/S's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bavarian Nordic A/S Margin History

Bavarian Nordic A/S Gross marginBavarian Nordic A/S Profit marginBavarian Nordic A/S EBIT marginBavarian Nordic A/S Profit margin
2029e65.18 %0 %0 %
2028e65.18 %29.98 %15.49 %
2027e65.18 %27.2 %12.72 %
2026e65.18 %20.04 %15.91 %
2025e65.18 %18.18 %14.1 %
2024e65.18 %16.8 %15.02 %
202365.18 %30.08 %20.89 %
202253.99 %-2.25 %-11.03 %
202130.08 %-16.49 %-24.49 %
202036.35 %21.36 %14.98 %
201946.45 %-49.58 %-52.34 %
201849.04 %-70.81 %-72.3 %
201778.79 %25.78 %13.24 %
201670.42 %3.52 %3.04 %
201559.32 %1.33 %5.82 %
201459.31 %1.37 %2.13 %
201360.02 %2.75 %-3.85 %
201249.49 %-3.12 %-23.61 %
201122.96 %-58.88 %-51.26 %
2010-41.52 %-150.94 %-124.13 %
2009-87.3 %-456.15 %-356.02 %
20085.8 %-100.34 %-69.97 %
200780.58 %-19.57 %-18.07 %
200622.25 %-116.26 %-90.13 %
200546.61 %-48.38 %-38 %
200457.34 %-49.94 %-32.16 %

Bavarian Nordic A/S Aktienanalyse

What does Bavarian Nordic A/S do?

Bavarian Nordic A/S is a biopharmaceutical company based in Denmark, specializing in the development and production of vaccines. The company was established in 1994 as a spin-off from the University of Copenhagen and has been listed on the Copenhagen stock exchange since 1998. The company's history began with an innovation developed by Professor Peter Andersen at the University of Copenhagen - the Viruslike Particles (VLP) technology. This technology serves as the basis for the production of vaccines against severe infectious diseases such as influenza, RSV, or HPV. Bavarian Nordic utilizes this technology to generate effective immune responses without using live pathogens. The company's business model is focused on two areas: the commercial vaccine sector and the biodefense products sector. The commercial sector includes the development and production of vaccines for cancer (such as prostate cancer or breast cancer) as well as infectious diseases like RSV. The biodefense products sector concentrates on protection against biological attacks, with the company manufacturing vaccines against bioweapons such as anthrax or smallpox for governmental institutions. Bavarian Nordic is divided into various business divisions. One of these is the commercial vaccines department, which develops and produces vaccines for the commercial market, particularly for cancer indications. The company also has a biodefense products department, which safeguards governmental institutions and organizations against bioterrorist attacks and other threats posed by biological weapons. This department focuses on the development and production of vaccines against smallpox, anthrax, and Ebola virus. Bavarian Nordic offers a wide range of products. The commercial vaccine Prostvac against prostate cancer is the company's flagship product. Other vaccines that have been developed or are still in development include vaccines against breast cancer, influenza, RSV, and lung cancer. The biodefense products encompass vaccines against smallpox, anthrax, and Ebola virus, as well as preclinical development programs for additional biological attacks. The company has also signed cooperation agreements with other companies to accelerate the research and development of new products. These include collaborations with Bristol Myers Squibb and Janssen Pharmaceutica for the development of cancer vaccines, as well as with the British Ministry of Defence for the development of vaccines against anthrax. Overall, Bavarian Nordic A/S caters to a broad range of interests and business sectors. The company focuses on the development and production of vaccines for both commercial and governmental institutions, aiming to enhance protection against biological threats and infectious diseases. Thanks to its innovative VLP technology, the company is a key player in the field of vaccine development and offers a wide range of products. Bavarian Nordic A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Bavarian Nordic A/S's Profit Margins

The profit margins of Bavarian Nordic A/S represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Bavarian Nordic A/S's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Bavarian Nordic A/S's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Bavarian Nordic A/S's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Bavarian Nordic A/S’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Bavarian Nordic A/S stock

How much profit has Bavarian Nordic A/S made this year?

Bavarian Nordic A/S has made 814.8 M DKK this year.

How has the profit developed compared to last year?

The profit has increased by -44.77% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Bavarian Nordic A/S publish its earnings?

Bavarian Nordic A/S publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Bavarian Nordic A/S?

The profits of Bavarian Nordic A/S are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Bavarian Nordic A/S?

You can learn more about the earnings of Bavarian Nordic A/S by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Bavarian Nordic A/S pay?

Over the past 12 months, Bavarian Nordic A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bavarian Nordic A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Bavarian Nordic A/S?

The current dividend yield of Bavarian Nordic A/S is .

When does Bavarian Nordic A/S pay dividends?

Bavarian Nordic A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bavarian Nordic A/S?

Bavarian Nordic A/S paid dividends every year for the past 0 years.

What is the dividend of Bavarian Nordic A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bavarian Nordic A/S located?

Bavarian Nordic A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bavarian Nordic A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bavarian Nordic A/S from 7/29/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did Bavarian Nordic A/S pay the last dividend?

The last dividend was paid out on 7/29/2024.

What was the dividend of Bavarian Nordic A/S in the year 2023?

In the year 2023, Bavarian Nordic A/S distributed 0 DKK as dividends.

In which currency does Bavarian Nordic A/S pay out the dividend?

The dividends of Bavarian Nordic A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bavarian Nordic A/S stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Bavarian Nordic A/S

Our stock analysis for Bavarian Nordic A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bavarian Nordic A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.